Qingsong Liu

40PUBLICATIONS
41CO-AUTHORS
Molecular targetsCancer therapy (excl. chemotherapy and radiation therapy)Speciation and extinctionBiologically active moleculesPharmacogenomics
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (40)

|Jun 17, 2026
Discovery of Dihydropyrimido-Pyrimidine-Based Bone Marrow Tyrosine Kinase Gene in Chromosome X Protein Proteolysis-Targeting Chimeras for the Treatment of Prostate Cancer.

|Apr 07, 2026
BMX inhibition overcomes small cell lung cancer chemoresistance by stabilizing E2F1 via ERK1/2-Cyclin D1/CDK4/6 axis.

Ting Wu, Shuang Qi, Chenliang Shi

|Mar 31, 2026
Timosaponin AIII enhances CAR-T cell potency and prevents relapse through impairing CAR-Tregs.

Mingqi Hou, Wenjun Zhang, Ziping Qi

|Dec 19, 2025
CDK3 induces neuronal death and brain atrophy in Alzheimer's disease.

Kai Zhuang, Liu Zi, Xiao Su

|Oct 13, 2025
Discovery of a 1H-Pyrazol-3-Amine Derivative as a Novel, Selective, and Orally Available RIPK1 Inhibitor for the Treatment of Inflammatory Disease.

Qiangqiang Tao, Xixiang Li, Hongwei Yu

|Oct 13, 2025
Discovery of Novel Purine Derivatives as Potent and Orally Bioavailable PGK1 Inhibitors for the Treatment of Inflammatory Bowel Disease.

Zhi Huang, Juan Ge, Yongfei Chen

Pageof 7

Frequent Collaborators

21 joint publications

Jing Liu

5 joint publications

Xiaofei Liang

2 joint publications

Zengqiang Yuan

2 joint publications

Hongbin Ji